Page last updated: 2024-08-07 16:37:44
P2Y purinoceptor 2
A P2Y purinoceptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P41231]
Synonyms
P2Y2;
ATP receptor;
P2U purinoceptor 1;
P2U1;
P2U receptor 1;
Purinergic receptor
Research
Bioassay Publications (30)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 17 (56.67) | 29.6817 |
2010's | 12 (40.00) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
Compounds (28)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
suramin | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
trypan blue | Homo sapiens (human) | IC50 | 171.0000 | 1 | 1 |
suramin sodium | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
a 803467 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
acid blue 40 | Homo sapiens (human) | IC50 | 5.8100 | 1 | 1 |
acid blue 25 | Homo sapiens (human) | IC50 | 11.1775 | 4 | 4 |
Drugs with Activation Measurements
Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide.Journal of medicinal chemistry, , Aug-14, Volume: 51, Issue:15, 2008
Purine and pyrimidine (P2) receptors as drug targets.Journal of medicinal chemistry, , Sep-12, Volume: 45, Issue:19, 2002
Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.Journal of medicinal chemistry, , Apr-28, Volume: 54, Issue:8, 2011
Purine and pyrimidine (P2) receptors as drug targets.Journal of medicinal chemistry, , Sep-12, Volume: 45, Issue:19, 2002
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.Bioorganic & medicinal chemistry letters, , Jan-22, Volume: 11, Issue:2, 2001
Current knowledge on the nucleotide agonists for the P2Y2 receptor.Bioorganic & medicinal chemistry, , 01-15, Volume: 26, Issue:2, 2018
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2YJournal of medicinal chemistry, , 10-26, Volume: 60, Issue:20, 2017
Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analogues.Bioorganic & medicinal chemistry, , Apr-01, Volume: 20, Issue:7, 2012
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.Bioorganic & medicinal chemistry, , Sep-15, Volume: 20, Issue:18, 2012
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.Journal of medicinal chemistry, , Jan-12, Volume: 55, Issue:1, 2012
Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.Journal of medicinal chemistry, , Apr-28, Volume: 54, Issue:8, 2011
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.Journal of medicinal chemistry, , Jun-23, Volume: 54, Issue:12, 2011
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.Journal of medicinal chemistry, , Feb-25, Volume: 53, Issue:4, 2010
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.Journal of medicinal chemistry, , Jun-10, Volume: 53, Issue:11, 2010
Identification of hydrolytically stable and selective P2Y(1) receptor agonists.European journal of medicinal chemistry, , Volume: 44, Issue:4, 2009
Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.Bioorganic & medicinal chemistry, , Jun-15, Volume: 16, Issue:12, 2008
New iantherans from the marine sponge Ianthella quadrangulata: novel agonists of the P2Y(11) receptor.Journal of medicinal chemistry, , Nov-15, Volume: 50, Issue:23, 2007
Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 17, Issue:2, 2007
Novel nucleotide triphosphates as potent P2Y2 agonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 17, Issue:2, 2007
Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.Journal of medicinal chemistry, , Mar-22, Volume: 50, Issue:6, 2007
Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.Journal of medicinal chemistry, , Nov-30, Volume: 49, Issue:24, 2006
Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.Journal of medicinal chemistry, , Mar-23, Volume: 49, Issue:6, 2006
Purine and pyrimidine (P2) receptors as drug targets.Journal of medicinal chemistry, , Sep-12, Volume: 45, Issue:19, 2002
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.Bioorganic & medicinal chemistry letters, , Jan-22, Volume: 11, Issue:2, 2001
Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Purine and pyrimidine (P2) receptors as drug targets.Journal of medicinal chemistry, , Sep-12, Volume: 45, Issue:19, 2002
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.Journal of medicinal chemistry, , Jan-12, Volume: 55, Issue:1, 2012
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.Journal of medicinal chemistry, , Feb-25, Volume: 53, Issue:4, 2010
Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.Bioorganic & medicinal chemistry, , Jun-15, Volume: 16, Issue:12, 2008
Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.Journal of medicinal chemistry, , Mar-22, Volume: 50, Issue:6, 2007
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.Journal of medicinal chemistry, , Jun-23, Volume: 54, Issue:12, 2011
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.Bioorganic & medicinal chemistry, , Jun-15, Volume: 16, Issue:12, 2008
Current knowledge on the nucleotide agonists for the P2Y2 receptor.Bioorganic & medicinal chemistry, , 01-15, Volume: 26, Issue:2, 2018
Purine and pyrimidine (P2) receptors as drug targets.Journal of medicinal chemistry, , Sep-12, Volume: 45, Issue:19, 2002
Current knowledge on the nucleotide agonists for the P2Y2 receptor.Bioorganic & medicinal chemistry, , 01-15, Volume: 26, Issue:2, 2018
Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.Journal of medicinal chemistry, , Apr-28, Volume: 54, Issue:8, 2011
Current knowledge on the nucleotide agonists for the P2Y2 receptor.Bioorganic & medicinal chemistry, , 01-15, Volume: 26, Issue:2, 2018
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.Journal of medicinal chemistry, , Feb-25, Volume: 53, Issue:4, 2010
Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.Journal of medicinal chemistry, , Mar-22, Volume: 50, Issue:6, 2007
Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.Journal of medicinal chemistry, , Nov-30, Volume: 49, Issue:24, 2006
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.Journal of medicinal chemistry, , Feb-25, Volume: 53, Issue:4, 2010
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.Bioorganic & medicinal chemistry, , Jun-15, Volume: 16, Issue:12, 2008
Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.Journal of medicinal chemistry, , Mar-22, Volume: 50, Issue:6, 2007
Development of Potent and Selective Antagonists for the UTP-Activated P2YJournal of medicinal chemistry, , 04-13, Volume: 60, Issue:7, 2017
Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.Journal of medicinal chemistry, , Feb-10, Volume: 54, Issue:3, 2011
Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.Journal of medicinal chemistry, , Mar-11, Volume: 53, Issue:5, 2010
Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 18, Issue:1, 2008
Enables
This protein enables 5 target(s):
Target | Category | Definition |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
signaling receptor activity | molecular function | Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response. [GOC:bf, GOC:signaling] |
G protein-coupled purinergic nucleotide receptor activity | molecular function | Combining with a purine nucleotide and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. [GOC:mah, PMID:9755289] |
A1 adenosine receptor binding | molecular function | Binding to an A1 adenosine receptor. [GOC:mah, GOC:nln] |
G protein-coupled UTP receptor activity | molecular function | Combining with a nucleotide and transmitting the signal to a heterotrimeric G-protein complex to initiate a change in cell activity, activated by UTP. [GOC:mah] |
Located In
This protein is located in 1 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Involved In
This protein is involved in 7 target(s):
Target | Category | Definition |
intracellular monoatomic ion homeostasis | biological process | A homeostatic process involved in the maintenance of a steady state level of monoatomic ions within a cell. Monatomic ions (also called simple ions) are ions consisting of exactly one atom. [GOC:mah] |
phospholipase C-activating G protein-coupled receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of phospholipase C (PLC) and a subsequent increase in the intracellular concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG). [GOC:dph, GOC:mah, GOC:signaling, GOC:tb, ISBN:0815316194] |
G protein-coupled purinergic nucleotide receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway initiated by an extracellular purine nucleotide binding to its receptor, and ending with the regulation of a downstream cellular process. [GOC:BHF, PMID:9755289] |
positive regulation of mucus secretion | biological process | Any process that activates or increases the frequency, rate or extent of the regulated release of mucus from a cell or a tissue. [GOC:add] |
cellular response to ATP | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus. [GOC:mah] |
blood vessel diameter maintenance | biological process | Any process that modulates the diameter of blood vessels. [GOC:pr] |
G protein-coupled receptor signaling pathway | biological process | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. [GOC:bf, GOC:mah, PMID:16902576, PMID:24568158, Wikipedia:G_protein-coupled_receptor] |